Alprazolam Extended-Release 3 mg Tablets

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions

CompletedNCT00829426

Teva Pharmaceuticals USAHealthy

Start: 2005-06-30End: 2005-06-30Updated: 2024-09-19

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

CompletedNCT00830024

Teva Pharmaceuticals USAHealthy

Start: 2005-06-30End: 2005-06-30Updated: 2024-08-20